This Solicitation opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

ISONIAZID TABLETS

Closed

SPE2DP-26-T-4184Federal

Submission Closed07/22/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Sodium Chloride Solution Manufacturing and Formulation

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Manufacturer of Insect Sting and Bite Treatment Paste

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing of Erythromycin Ophthalmic Ointment

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

INSECT STING AND BITE

Solicitation # SPE2DP-26-T-4785

This contract is for the procurement of insect sting and bite treatment paste, specifically the Mitigator product from American Natural Technology Sciences. The item is supplied in half-ounce re-sealable packets, with each package containing 12 units. The total order quantity is for 3 packages, and the product must be stored at room temperature. The agreement specifies a delivery timeframe of 84 days with shipping and inspection occurring at the destination. Compliance with Medical Marking Standard No. 1 and DLA packaging requirements is mandatory. As the product is regulated by the FDA, the contracting official must coordinate with a product specialist for confirmation, and the supplier must provide detailed manufacturer and part number information.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ERYTHROMYCIN OPHTHALMI

Solicitation # SPE2DP-26-T-4791

This contract is for the procurement of Erythromycin Ophthalmic Ointment, USP, with a strength of 5 mg/gram (0.5 percent). The product consists of sterile single dose tubes of 3.5 grams each, provided in packages of 24 tubes. The total shelf life is 36 months, and the item must have a minimum of 31 months of remaining shelf life upon receipt by the government. Storage must be maintained at a controlled room temperature between 15 and 30 degrees Celsius, avoiding excessive heat and freezing. The order specifies a quantity of two packages to be delivered FOB destination to the Medical Logistics command at Fort Bragg, North Carolina, within five days after the order. Packaging and marking must comply with Medical Marking Standard No. 1 and DLA packaging requirements, ensuring the use of suitable sealed unit containers and commercial exterior shipping containers. This is an FDA-regulated drug and requires specific coordination between the contracting official and product specialist for confirmation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4786

This contract is for the procurement of Clotrimazole 1% Cream, provided in 15 gram tubes. The requirement specifies a total quantity of 22 units to be delivered to Fort Bragg, North Carolina. The product must be dispensed in tight, light-resistant containers with child-resistant closures and stored between 20 to 25 degrees Celsius. The cream has a total shelf life of 36 months, with a minimum of 31 months remaining at the time of receipt by the government. Packaging and labeling must adhere to DLA packaging requirements and Medical Marking Standard No. 1A. Additionally, the contract prohibits the intentional addition of mercury or mercury-containing compounds to the supplies. Delivery is required within 20 days, with inspection and acceptance occurring at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4789

This contract is for the procurement of Dextrose Injection 5%, USP, provided in 1,000 ML sterile, nonpyrogenic, latex-free single-dose bags. The product is intended for intravenous administration and is supplied in packages containing 12 bags each. It must be stored at controlled room temperature between 20 and 25 degrees Celsius and has a non-extendable shelf life of 30 months. The item must be marked according to Medical Marking Standard No. 1 and comply with DLA packaging and quality requirements. The solicitation, identified as SPE2DP-26-T-4789, specifies a quantity of one package with a delivery requirement of 20 days after the order. Delivery is FOB destination, with the final shipment destined for the USS IOWA via Submarine Base New London. The contract mandates strict adherence to DLA Master List technical requirements and MIL-STD-129 for labeling and packaging. The original required delivery date is set for April 8, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4787

This contract is for the procurement of sterile, distilled, and nonpyrogenic water for irrigation, intended for washing, rinsing, and dilution purposes. The product consists of 1000 ml semi-rigid plastic containers with screw caps, provided in packages of 12 units each. It is a prescription-only item regulated by the FDA and must be stored at controlled room temperatures between 20 and 25 degrees Celsius. The item has a non-extendable shelf life of 36 months and must adhere to Medical Marking Standard No. 1 and DLA packaging requirements. The order includes multiple line items for delivery to the USS Albany and USS Oregon, with a delivery timeframe of 20 days. Shipments must be made via the fastest traceable means and are designated as FOB destination. All packaging and labeling must comply with MIL-STD-129 and DLA technical requirements, with specific instructions for both hazardous and non-hazardous materials. The contract specifies a zero percent quantity variance and requires inspection and acceptance at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

HYDROXYPROPYL METHYLCE

Solicitation # SPE2DP-26-T-4784

Contract SPE2DP-26-T-4784 is a solicitation issued by the Department of Defense Medical Supply Chain Pharm FSA for OcuCoat Viscoelastic Hydroxypropyl Methylcellulose Ophthalmic Solution. The product is a 2 percent solution in 1ml units, designed for high-volume, small-incision cataract surgery and lens inserter lubrication. The requirement is for six boxes, with each box containing six units, under NSN 6505-01-633-1037 and Bausch and Lomb part number CC065S. The item is FDA regulated and must adhere to a non-extendable 24-month shelf life. Delivery is required within 79 days after order, with the destination being the USA Medical Materiel Center Europe in Kaiserslautern, Germany. The contract mandates strict adherence to Medical Marking Standard No. 1 for labeling, which must include the national stock number, manufacturer, date of manufacture, expiration or retest date, contract number, and lot number. Packaging must be commercial grade, utilizing sealed unit containers and suitable exterior shipping containers to prevent damage. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Radiopharmaceuticals and Cold Kits (Core CLINs)

Defense Health Agency

POSTED

DEADLINE

6505--FY27 SIR-Spheres Y90 Resin Microspheres

Solicitation # 36C24826Q0954

The Department of Veterans Affairs intends to award a sole source, firm-fixed price purchase order to Sirtex Medical Inc. for the procurement of SIR-Spheres Y90 Resin Microspheres and associated accessory kits for the Bay Pines VA Health Care System. The requirement includes ten dose and administration kits, one delivery dome, ten prep sets, and ten delivery sets. This procurement is justified as a sole source action due to the unique, specialized, and proprietary nature of the supplies, which the government believes only Sirtex Medical Inc. can provide. While this notice is not a formal request for competitive proposals, interested parties may submit quotations and evidence of their capability to meet the requirements to determine if a competitive procurement is warranted. All responses must be submitted to the contracting officer, Cindy Smith, by 10 AM Eastern Standard Time on September 14, 2026. If no qualified responses are received, the government will proceed with the sole source acquisition from the identified vendor.

248-NETWORK Contract Office 8 (36C248)

POSTED

DEADLINE

FDA-Approved Radiopharmaceutical Supplies and Cold Kits

Solicitation # HT9406-26-Q-E102

The Defense Health Agency is seeking a contractor to provide all necessary personnel, equipment, and materials for the continuous custom compounding and delivery of FDA-approved radiopharmaceuticals and cold kits. These supplies are to be delivered to the Nuclear Medicine Section at the Dwight David Eisenhower Army Medical Center located at Fort Gordon, Georgia. This combined solicitation, numbered HT9406-26-Q-E102, falls under NAICS code 325412. The response deadline for this opportunity is September 10, 2026, and there are no specific set-aside restrictions applied to this contract.

Defense Health Agency

POSTED

3 days ago

DEADLINE

in 10 days

AI Contract Overview

ISONIAZID TABLETS USP, 300 MG, in 100-count bottles, are being procured under solicitation SPE2DP-26-T-4184 with a unit of issue of bottle (BT), and the sole quantity is one bottle. The item is subject to a non-extendable shelf life of 36 months as a Type I (Code Q) pharmaceutical, requiring storage at medical controlled room temperature. The drug is regulated by the FDA, and any bidder must provide bidder and manufacturer details, including NDC numbers for Marlex Pharmaceuticals Inc and Genus LifeSciences Inc, for official confirmation. Delivery is required FOB destination within 20 days of order placement, with the original delivery date set for July 20, 2026. The consignee is the USNS Leroy Grumman at FPO AE 09570, and shipments must be sent via traceable freight methods, excluding parcel post. Packaging must comply with the DLA Master List of Technical and Quality Requirements, which supersedes ASTM D3951, and must be marked in accordance with MIL-STD-129, including GS1-128 barcodes. Palletization must adhere to RP001, and hazardous material packaging, if applicable, must follow TQ Requirement IP025 under FED-STD-313. Mercury or mercury-containing compounds are prohibited in direct contact with the product except for specific exempted uses such as certain instruments or sensors, which must have shockproof enclosures and a secondary containment layer per NAVSEA 5100-003D. The supplier must comply with all applicable FAR and DFARS clauses, including cybersecurity requirements under 252.204-7012 and 252.240-7997, trafficking in persons prohibitions, employment eligibility verification, sustainable procurement standards, and whistleblower protections. All invoices must be processed through Wide Area WorkFlow (WAWF), and inspection and acceptance occur at the destination. Contract clauses mandate compliance with hazard communication standards, electronic invoicing protocols, and supply chain security restrictions on telecommunications equipment. The solicitation does not specify pricing, option quantities, or evaluation factors beyond potential automated award under simplified acquisition procedures.

General Info

ISONIAZID 300 MG tablets, 100/bottle, FDA-regulated, 36-month shelf life, FOB destination July 20, 2026, Marlex or Genus only, NSN 6505-00-132-6904

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

UNIT 100371 BOX 1, FPO, AE, 09570, USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4184 for Medical Supply Chain

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedJul 16

Solicitation

Response DeadlineJul 22

Deadline has passed

Submission Closed

07/22/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressUSA

Contacts

Vanesa M Carbo Acevedo

contact@example.gov

+1 (555) 000-0000

Full Description

ISONIAZID TABLETS
ISONIAZID TABLETS<(>,<)> USP, 300 MG,100'S UNIT OF ISSUE "BOTTLE". Store at medical controlled room temperature.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
MERCURY OR MERCURY CONTAINING COMPOUNDS SHALL
NOT BE INTENTIONALLY ADDED TO<(>,<)> OR COME IN DIRECT
CONTACT WITH<(>,<)> ANY HARDWARE OR SUPPLIES FURNISHED
UNDER THIS CONTRACT. EXCEPTION: FUNCTIONAL MERCURY
USED IN BATTERIES, FLUORESCENT LIGHTS, REQUIRED
INSTRUMENTS; SENSORS OR CONTROLS; WEAPON SYSTEMS;
AND CHEMICAL ANALYSIS REAGENTS SPECIFIED BY NAVSEA.
PORTABLE FLUORESCENT LAMPS AND PORTABLE INSTRUMENTS
CONTAINING MERCURY SHALL BE SHOCK PROOF AND CONTAIN
A SECOND BOUNDARY OF CONTAINMENT OF THE MERCURY OR
MERCURY COMPOUND. (IAW NAVSEA 5100-003D).
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
MARLEX PHARMACEUTICALS INC 1TAP7 P/N NDC10135080501 GENUS LIFESCIENCES INC 7BH52 P/N NDC64950-0217-10
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4184
SECTION B
PR: 7017516553 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017516553 0001 BT 1.000
NSN/MATERIAL:6505001326904
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N21525
USNS LEROY GRUMMAN T AO 195
UNIT 100371 BOX 1
FPO AE 09570
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
N21525
USNS LEROY GRUMMAN T AO 195
DLA VENDORS: USE VSM FOR
US
M/F: (TCN) N215256196S408
RDD: 777
PROJ: HJ5 TP 2
SUPP ADD: YCAB A SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A4A DIST: 9B ADV: 2A FC: E5
Need Ship Date:00/00/0000 Original Required Delivery Date:07/20/2026
SPE2DP-26-T-4184
SECTION B
PR: 7017516553 PRLI: 0001 CONT’D

SPE2DP-26-T-4184 NSN/Part Number: 6505-00-132-6904 Quantity: 1 BT Purchase Request: 7017516553QTY: 1 Delivery: 20 days ADO